Table 3.
Study (Reference Number) | Country/Region | Sample size | Study design | Study population | Outcome studied | Results |
---|---|---|---|---|---|---|
Ilie et al. 2020 [16] | 20 countries in Europe | n ≥ 45,000 (as of 8 April 2020) | Cross sectional-Observational prognostic | General Population | The correlation between mean serum 25(OH)D level and COVID-19 cases and mortalities by country | A negative correlation observed between 25(OH)D levels and the number of COVID-19 cases (p = 0.050) and mortalities per million population (p = 0.05) respectively |
D’Avolio et al. 2020 [73] | Switzerland | n = 1484 (107 COVID-19 positive/negative cohort from 1 March-14 April 2020 AND n = 1377 control patients from 1March-14 April 2019 | Retrospective Cohort | General Population | Serum 25(OH)D concentrations in SARS-CoV-2 PCR positive patients compared with PCR-negative patients from 2020 cohort and historic controls from 2019. The association between serum 25(OH)D status and COVID-19 infection | Significantly lower 25(OH)D levels seen in 2020 SARS-CoV-2 PCR positive cohort [11.1 ng/ml] compared with 2020 PCR negative cohort [24.6 ng/ml] (p = 0.004) A similar association seen when 2020 SARS-CoV-2 PCR positive cohort [11.1 ng/ml] compared to 2019 historic controls [24.6 ng/ml] (p < 0.001) |
Fasano et al. 2020 [74] | Italy | n = 2693 (1486 patients with Parkinson’s disease [PD] and 1207 controls) | Case control Survey | Patients with Parkinson’s Disease | Primary Outcome: Risk of Developing COVID-19 in PD patients Secondary Outcome: The risk factors for COVID-19 infection in PD patients |
22.4% of PD patients on vitamin D supplementation did not develop COVID-19 while 12.4% of PD patients who did not take vitamin D supplementation developed COVID-19 Age adjusted OR: 0.56 (95% CI:0.32–0.99); (p = 0.048) |
Hastie et al. 2020 [75] | UK | n = 348,598 (UK Biobank participants aged 37–73 years between 16 March 2020 to 14 April 2020) | Observational Prognostic using univariate and multivariate regression | General Population- UK Biobank participants across England, Scotland, and Wales | The prediction between baseline 25(OH)D status and subsequent COVID-19 infection | 25(OH)D levels showed a significant association with COVID-19 infection in univariate analysis (p = 0.013) but not after adjustment for confounders (p = 0.208) |
Laird et al. 2020 [76] | 12 countries in Europe | n = 21,769 | Cross sectional -Observational Prognostic using correlation | Older adults | The correlation between serum 25(OH)D status by country and COVID-19 mortalities | A statistically significant correlation between low mean serum 25(OH)D levels and higher rate of COVID-19 mortalities per million population (p = 0.046) |